Amniotic fluid stem cells and their application in cell-based tissue regeneration

International Journal of Fertility and Sterility

Volumn 6, Issue 3, 2012, Pages 147-156

  Eslaminejad, Mohamadreza Baghaban ^a   Jahangir, Shahrbanoo ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

Amniotic Fluid; Mesenchymal Stem Cells; Stem Cells; Tissue Engineering; Tissue Regeneration

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; BETA1 INTEGRIN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKERATIN 18; ENDOGLIN; HERMES ANTIGEN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; PODOCALYXIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 3; STEM CELL FACTOR; THY 1 ANTIGEN;

AMNIOTIC FLUID CELL; BONE; CARTILAGE; CELL ISOLATION; CELL REGENERATION; FETUS (ANATOMY); HUMAN; KIDNEY; LUNG; NERVOUS TISSUE; NONHUMAN; REVIEW; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 84871805942     PISSN: 2008076X     EISSN: 20080778     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Bajada S, Mazakova I, Richardson JB, Ashammakhi N. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med. 2008; 2(4): 169-183.
2. Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med. 2008; 3(1): 1-5.
3. Langer R, Vacanti JP. Tissue engineering. Science. 1993; 260(5110): 920-926.
4. Laurencin CT, Ambrosio AM, Borden MD, Cooper JA Jr. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng. 1999; 1: 19-46.
5. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004; 116(5): 639-648.
6. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003; 21: 759-806.
7. Gage F H. Mammalian neural stem cells. Science. 2000; 287(5457): 1433-1438.
8. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004; 95(4): 343-353.
9. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007; 449(7165): 1003-1007.
10. Roisen FJ, Klueber KM, Lu CL, Hatcher LM, Dozier A, Shields CB. Adult human olfactory stem cells. Brain Res. 2001; 890(1): 11-22.
11. de Rooij DG. Stem cells in the testis. Int J Exp Pathol. 1998; 79(2): 67-80.
12. Conrad S, Renninger M, Hennenlotter J, Wiesner T, Just L, Bonin M, et al. Generation of pluripotent stem cells from adult human testis. Nature. 2008; 456(7220): 344-349.
13. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966; 16(3): 381-390.
14. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970; 3(4): 393-403.
15. Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multiorgan failure syndrome. J Gene Med. 2003; 5(12): 1028-1038.
16. Sugaya K. Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases. Int Rev Cytol. 2003; 228:1-30.
17. Eslaminejad MB, Nikmahzar A, Taghiyar L, Nadri S, Massumi M. Murine mesenchymal stem cells isolated by low density primary culture system. Dev Growth Differ. 2006; 48(6): 361-370.
18. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell. 2001; 105(7): 829-841.
19. Barry FP. Mesenchymal stem cell therapy in joint disease. Novartis Found Symp.2003;249: 86-96.
20. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulategrowth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A.2002; 99(13):8932-8937.
21. Koç ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologousblood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000; 18(2): 307-316.
22. Petite H, Viateau V, Bensaïd W, Meunier A, de Pollak C, Bourguignon M, et al. Tissue-engineered bone regeneration. Nat Biotechnol. 2000; 18(9): 959-963.
23. Grinnemo KH, Månsson A, Dellgren G, Klingberg D, Wardell E, Drvota V, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg. 2004; 127(5): 1293-1300.
24. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004; 22(5): 675-682.
25. Nishida S, Endo N, Yamagiwa H, Tanizawa T, Takahashi HE. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab. 1999; 17(3): 171-177.
26. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292(5819): 154-156.
27. Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc. 2009; 84(10): 893-902.
28. Li F, Bronson S, Niyibizi C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem. 2010; 109(4): 643-652.
29. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000; 2(6): 477-488.
30. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001; 98(8): 2396-2402.
31. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1): 235-242.
32. Ghionzoli M, Cananzi M, Zani A, Rossi CA, Leon FF, Pierro A, et al. Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int. 2010; 26(1): 79-84.
33. Parolini O, Soncini M, Evangelista M, Schmidt D. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med.2009; 4(2): 275-291.
34. Brace RA, Resnik R. Dynamics and disorders of amniotic fluid: maternal Fetal medicine. Philadelphia: Saunders; 1999;623-643.
35. Olver RE, Strang LB. lon fluxes across the pulmonary epithelium and the secretion of lung liquid in the foetal lamb. J Physiol. 1974; 241(2): 327-357.
36. Mescher EJ, Platzker AC, Ballard PL, Kitterman JA, Clements JA, Tooley WH. Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb. J Appl Physiol.1975; 39(6): 1017-1021.
37. Modena AB, Fieni S. Amniotic fluid dynamics. Acta Biomed.2004; 75 Suppl 1: 11-13.
38. Seeds AE. Current concepts of amniotic fluid dynamics. Am J Obstet Gynecol. 1980; 138(5): 575-586.
39. Albuquerque CA, Nijland MJ, Ross MG. Human and ovine amniotic fluid composition differences: implications for fluid dynamics. J Matern Fetal Med. 1999; 8(3): 123-129.
40. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2004; 18(6): 877-891.
41. Milunsky A. Genetic disorders and the fetus: diagnosis, prevention and treatment. Baltimore: The Johns Hopkins University Press; 1998:128-149.
42. Hoehn H, Salk D. Morphological and biochemical heterogeneity of amniotic fluid cells in culture. Methods Cell Biol.1982; 26: 11-34.
43. Gosden CM. Amniotic fluid cell types and culture. Br Med Bull.1983; 39(4): 348-354.
44. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschläger M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod. 2003; 18(7): 1489-1493.
45. Prusa AR, Hengstschlager M. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit. 2002; 8(11): RA253-257.
46. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 2007; 40(1): 75-90.
47. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, Chang YJ. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod. 2006; 74(3): 545-551.
48. rd ed. USA: Johns Hopkins University Press; 1992: 101-117.
49. Tsai MS, LeeJL, Chang YJ, Hwang SM, Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel twostage culture protocol. Hum Reprod. 2004; 19(6): 1450-1456.
50. Torricelli F, Brizzi L, Bernabei PA, Gheri G, Di Lollo S, Nutini L, et al. Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. Ital J Anat Embryol. 1993; 98(2): 119-126.
51. Streubel B, Martucci-Ivessa G, Fleck T, Bittner RE. In vitro transformation of amniotic cells to muscle cells--background and outlook. Wien Med Wochenschr. 1996; 146(9-10): 216-217.
52. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003; 102(4): 1548-1549.
53. Prusa AR, Marton E, Rosner M, Bettelheim D, Lubec G, Pollack A, et al. Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol. 2004; 191(1): 309-314.
54. McLaughlin D, Tsirimonaki E, Vallianatos G, Sakellaridis N, Chatzistamatiou T, Stavropoulos-Gioka C, Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells. J Neurosci Res. 2006; 83(7): 1190-1200.
55. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007; 25(1): 100-106.
56. You Q, Tong X, Guan Y, Zhang D, Huang M, Zhang Y, et al. The biological characteristics of human third trimester amniotic fluid stem cells. J Int Med Res. 2009; 37(1): 105-112.
57. Baghaban Eslaminejad M, Jahangir S, Aghdami N. Mesenchymal stem cells from murine amniotic fluid as a model for preclinical investigation. Arch Iran Med. 2011; 14(2): 96-103.
58. Baghaban Eslaminejad M, Jahangir S, Aghdami N. Comparison of proliferation, senescence and differentiation into skeletal cell lineages of murine bone marrow-derived and amniotic fluid mesenchymal stem cells. Iran Red Crescent Med J. 2010; 12(6): 615-623.
59. Mosquera A, Fernández JL, Campos A, Goyanes VJ, Ramiro-Díaz J, Gosálvez J. Simultaneous decrease of telomere length and telomerase activity with ageing of human amniotic fluid cells. J Med Genet. 1999; 36(6): 494-496.
60. Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell. 1990; 63(1): 203-211.
61. Shamblott MJ, Axelman J, Littlefield JW, Blumenthal PD, Huggins GR, Cui Y, et al. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci USA. 2001; 98(1): 113-118.
62. Priest RE, Marimuthu KM, Priest JH. Origin of cells in human amniotic fluid cultures: ultrastructural features. Lab Invest. 1978; 39(2): 106-109.
63. Barry FP, Boynton RE, Haynesworth S, Murphy JM, Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun. 1999; 265(1): 134-139.
64. Barry F, Boynton R, Murphy M, Haynesworth S, Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun. 2001; 289(2): 519-524.
65. Kannagi R, Cochran NA, Ishigami F, Hakomori S, Andrews PW, Knowles BB, et al. Stage-specific embryonic antigens (SSEA-3 and-4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J. 1983; 2(12): 2355-2361.
66. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, et al. Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008;17(6): 1095-1107.
67. Klemmt PA, Vafaizadeh V, Groner B. Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. Stem Cell Res Ther. 2010; 1(3): 20.
68. Sessarego N, Parodi A, Podestà M, Benvenuto F, Mogni M, Raviolo V, et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica. 2008; 93(3): 339-346.
69. De Rosa A, Tirino V, Paino F, Tartaglione A, Mitsiadis T, Feki A, et al. Amniotic fluid-derived cells. mesenchymal stem cells lead to bone differentiation when cocultured with dental pulp stem. Tissue Eng Part A. 2011; 17(5-6): 645-653.
70. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol. 2004; 270(2): 488-498.
71. Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat. 2002; 200(Pt 3): 249-258.
72. Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM, Fauza DO. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001; 36(11): 1662-1665.
73. Kunisaki SM, Jennings RW, Fauza DO. Fetal cartilage engineering from amniotic mesenchymal progenitor cells. Stem Cells Dev. 2006; 15(2): 245-253.
74. Kunisaki SM, Fuchs JR, Kaviani A, Oh JT, LaVan DA, Vacanti JP, et al. Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte-and myoblast-based constructs. J Pediatr Surg. 2006; 41(1): 34-39.
75. Cipriani S, Bonini D, Marchina E, Balgkouranidou I, Caimi L, Grassi Zucconi G, et al. Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain. Cell Biol Int. 2007; 31(8): 845-850.
76. Pan HC, Cheng FC, Chen CJ, Lai SZ, Lee CW, Yang DY, et al. Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. J Clin Neurosci. 2007; 14(11): 1089-1098.
77. Cheng FC, Tai MH, Sheu ML, Chen CJ, Yang DY, Su HL, et al. Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury. J Neurosurg. 2010; 112(4): 868-879.
78. Pan HC, Chen CJ, Cheng FC, Ho SP, Liu MJ, Hwang SM, et al. Combination of G-CSF administration and human amniotic fluid mesenchymal stem cell transplantation promotes peripheral nerve regeneration. Neurochem Res. 2009; 34(3): 518-527.
79. Pan HC, Yang DY, Ho SP, Sheu ML, Chen CJ, Hwang SM, et al. Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extracts, Natto. J Biomed Sci. 2009; 23: 16-75.
80. Yeh YC, Wei HJ, Lee WY, Yu CL, Chang Y, Hsu LW, et al. Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies. Tissue Eng Part A. 2010; 16(6): 1925-1936.
81. Yeh YC, Lee WY, Yu CL, Hwang SM, Chung MF, Hsu LW, et al. Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. Biomaterials. 2010; 31(25): 6444-6453.
82. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tioz zo C, Lee J, et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells. 2008; 26(11): 2902-2911.
83. Perin L, Sedrakyan S, Giuliani S, Da Sacco S, Carraro G, Shiri L, et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One. 2010; 5(2): e9357.
84. Peister A, Woodruff MA, Prince JJ, Gray DP, Hutmacher DW, Guldberg RE. Cell sourcing for bone tissue engineering: amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cells. Stem Cell Res. 2011; 7(1): 17-27.
85. Peister A, Deutsch ER, Kolambkar Y, Hutmacher DW, Guldberg RE. Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng Part A. 2009; 15(10): 3129-3138.
86. Sun H, Feng K, Hu J, Soker S, Atala A, Ma PX. Osteogenic differentiation of human amniotic fluidderived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials. 2010; 31(6): 1133-1139.
87. Maraldi T, Riccio M, Resca E, Pisciotta A, La Sala GB, Ferrari A, et al. Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix. Tissue Eng Part A. 2011; 17(21-22): 2833-2843.
88. Riccio M, Maraldi T, Pisciotta A, La Sala GB, Ferrari A, Bruzzesi G, et al. Fibroin Scaffold repairs critical size bone defects in vivo supported by Human Amniotic Fluid and Dental Pulp Stem Cells. Tissue Eng Part A. 2012; 18(9-10): 1006-1013
89. Kolambkar YM, Peister A, Soker S, Atala A, Guldberg RE. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol. 2007; 38(5): 405-413.